Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008744 |
ID: | TCMBANKHE008744 |
植物拉丁名: |
|
功能与主治: | To dissipate wind and brighten eyes, precipitate qi and move blood./Headache, itchy body, red eyes and eye screen, convulsion, fullness in chest, cough and counterflow, concretion and conglomeration, difficult lactation, welling abscess and flat abscess, scrofula. |
药用植物名: | 刺蒺藜 |
药用部位: | fruit |
药味: | Warm; Bitter |
经络: | Lung; Liver |
治疗类型: | 平肝息风 |
TCM_ID_id: | 7158 |
TCMSP_id: | 124 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000065 | dioscin | LMST01080053; C08897; 3-O-(Rhaa1-4(Rhaa1-2)Glcb)-(25R)-spirost-5-en-3beta-ol; dioscin ; 19057-60-4; Dioscin | C45H72O16 | 869.04 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 |
| TCMBANKIN000843 | f-gitonin | C50H82O23 | 1051.2 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CC(C(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)C)C)C)OC1 | |
| TCMBANKIN003690 | terrestriamide | C18H17NO5 | 327.3 g/mol | COC1=C(C=CC(=C1)C=CC(=O)NCC(=O)C2=CC=C(C=C2)O)O | |
| TCMBANKIN008740 | 25(R)spirost-5-en-3beta-ol-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylylpyranylosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-beta-d-galactopyranose | 3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-galactopyranosyl-25(S and R)-spirost-5-en-3beta,14alpho-diol | 1049.3 | ||
| TCMBANKIN010574 | Gitoxigenin | CHEBI:38105; ST5308210; .delta.(20,22)-2,14,16,21-(Tetrahydroxy)norcholenic acid lactone; 5beta,20(22)-Cardenolide-3beta,14,16beta-triol; MEGxp0_001900; 16.beta.-Hydroxydigitoxigenin; gitoxigenin; ZINC03978407; 5.beta.-Card-20(22)-enolide, 3.beta.,14,16.beta.-trihydroxy-; .delta.20,(22)-2,14,16,21-(Tetrahydroxy)norcholenic acid lactone; NSC407807; 16.beta.-Hydroxydisitoxigenin; 3beta,14,16beta-Trihydroxy-5beta,20(22)-cardenolide; 3beta,14,16beta,21-Tetrahydroxy-20(22)-norcholenic acid lactone; 4-[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-3,14,16-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one; 545-26-6; Card-20(22)-enolide, 3,14,16-trihydroxy-, (3.beta.,5.beta.,16.beta.)-; NCI60_003893; G4635_SIGMA | C23H34O5 | 390.51 | CC12CCC(CC1CCC3C2CCC4(C3(CC(C4C5=CC(=O)OC5)O)O)C)O |
| TCMBANKIN012606 | Dioscoreside C | 26-O-beta-D-glucopyranosyl-3beta,26-dihydroxy-23S-methoxy-25(R)-furosta-5,20(22)-dien-3-O-alpha-L-rhamnopyranosyl(1-2)-[alpha-L-rhamnopyranosyl(1-4)]-beta-D-glucopyranoside; 3-O-(Rhaa1-4(Rhaa1-2)Glcb)-26-O-(Glcb)-23S-methoxy-(25R)-furosta-5,20(22)-dien-3beta,26-diol; LMST01070010; dioscoreside c | C53H88O22 | 1077.3 g/mol | CCC1C(CC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)OC6C(C(C(C(O6)C)O)O)O)O)OC7C(C(C(C(O7)C)O)O)O)C)C)OC(=C)C(CC(C)COC8C(C(C(C(O8)CO)O)O)O)OC |
| TCMBANKIN013700 | tribulusamide b | C36H34N2O9 | 638.7 g/mol | COC1=CC(=CC2=C1OC(C2C(=O)NCC(=O)C3=CC=C(C=C3)O)C4=CC(=C(C=C4)O)OC)C=CC(=O)NCCC5=CC=C(C=C5)O | |
| TCMBANKIN022787 | Gitonin | gitonin | C50H82O23 | 1051.17 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CC(C(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)C)C)C)OC1 |
| TCMBANKIN023430 | Desglucolanatigonin II | desglucolanatigonin ii | C50H82O22 | 1035.2 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)C)C)C)OC1 |
| TCMBANKIN024506 | terrestrosin d | C50H80O23 | 1049.2 g/mol | CC1CCC2(C(C3C(O2)CC4C3(C(=O)CC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)C)C)C)OC1 | |
| TCMBANKIN029134 | kaikasaponinIII | 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[(9-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl)oxy]oxane-2-carboxylic acid; AC1Q5V6O; AC1L4MPD; Kaikasaponin III; 22-hydroxyolean-12-en-3-yl 6-deoxyhexopyranosyl-(1-; 115330-90-0; kaikasaponin iii; kaikasaponin III; SCHEMBL14708535 | C48H78O17 | 927.12 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(C(OC3OC4CCC5(C(C4(C)C)CCC6(C5CC=C7C6(CCC8(C7CC(CC8O)(C)C)C)C)C)C)C(=O)O)O)O)CO)O)O)O)O)O |
| TCMBANKIN035964 | harmol | C12H10N2O | 198.22 g/mol | CC1=C2C(=C3C=CC(=O)C=C3N2)C=CN1 | |
| TCMBANKIN036865 | gracillin | CCRIS 4124; 19083-00-2; beta-D-Glucopyranoside, (3beta,25R)-spirost-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-3))-; NSC 698787; C08901; gracillin | C48H78O16 | 911 | C1([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]4([H])[C@]([H])(O[C@]5(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H]) [H])C([H])([H])O5)[C@@]4([H])C([H])([H])[H])C6([H])[H])[C@@]36[H])C([H])([H])[C@@]1([H])OOC([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])O[H])[C@]7([H])O[C@@]([H])(O[C@]([H])(C([H])([H])[H])[C @]8([H])O[H])[C@@]([H])(O[H])[C@]8([H])O[H])[C@@]([H])(C([H])([H])O[C@@]([H])(O[C@]([H])(C([H])([H])[H])[C@]9([H])O[H])[C@@]([H])(O[H])[C@]9([H])O[H])[C@]7([H])O[H] |
| TCMBANKIN038488 | Protogracillin | p-rotogracillin | 1065.2 | ||
| TCMBANKIN039332 | Proto-iso-eruboside B | C57H96O30 | 1261.4 g/mol | [C@]1([H])(C([H])([H])[H])[C@@](O[H])(C([H])([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)O[C@]([H])(C([H] )([H])[C@@]([H])([C@@]([H])(C([H])([H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[C@]4([H])[C@]([H])(O[C@@]5([H])[C@]([H])(O[H])[C@@]([H])(O [H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O5)[C@@]([H])(O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O6)[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O4)[C@@]([ H])(C([H])([H])O[H])O3)C([H])([H])C7([H])[H])[C@]78C([H])([H])[H])[C@@]8([H])C([H])([H])C9([H])[H])[C@@]9%10C([H])([H])[H])[C@@]1%10[H] | |
| TCMBANKIN042840 | 7beta,9alpha,10beta-tricetoxy-2alpha,5alpha,13alpha-trihydroxy-4(20),11-taxadiene | C27H40O8 | |||
| TCMBANKIN044911 | Terrestribisamide | 440.5 g/mol | |||
| TCMBANKIN048426 | Ruscogenin | C27H42O4 | 431 | C1([H])([H])[C@@]([H])(O[H])[C@@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]4([H])[C@]([H])(O[C@@]5(OC([H])([H])[C@]([H])(C([H])([H])[H])C ([H])([H])C5([H])[H])[C@@]4([H])C([H])([H])[H])C6([H])[H])[C@@]36[H])C([H])([H])[C@@]1([H])O[H] | |
| TCMBANKIN049764 | Terreside B | 754.9 g/mol | |||
| TCMBANKIN049991 | 26-O-β-D-Glucopyranosyl-(25S)-3β,5β,6α,22ξ,26-pentahydroxyl-5β-furostane 3-O-α-L-rhamnopyranosyl-(1→4)-β-D-glucopyranoside | ||||
| TCMBANKIN058400 | tribulusterine | C16H12N2O2 | 264.28 g/mol | C1=CC=C2C(=C1)C3=C(N2)C(=NC=C3)C4=C(C=CO4)CO | |
| TCMBANKIN059595 | desglucomusennin | C45H72O16 | 869 g/mol | CC1(CCC2(C(C1)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)C)OC6C(C(C(CO6)O)O)OC7C(C(C(CO7)O)O)OC8C(C(C(CO8)O)O)O)C)C(=O)O)C | |
| TCMBANKIN059762 | 26-o-β-d-glucopyranosyl(25r,s)-5α-furo-stane-12-one-20(22)-en-3β,26-diol-3-o-β-d-glucopyranosyl-(1→4)-β-d-galactopyranoside | C45H72O19 | CC1=C(OC2C1C3(C(C2)C4CCC5CC(CCC5(C4CC3=O)C)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)CO)O)O)O)O)O)C)CCC(C)COC8C(C(C(C(O8)CO)O)O)O | ||
| TCMBANKIN060060 | harmine | C13H12N2O | 212.25 | CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC | |
| TCMBANKIN060095 | Gitoxigenin | C23H34O5 | 390.51 | CC12CCC(CC1CCC3C2CCC4(C3(CC(C4C5=CC(=O)OC5)O)O)C)O | |
| TCMBANKIN060223 | 28-o-β-d-glucopyranosyl-(1→6)-β-d-glucopy-ranosyl ester of 3-o-[β-d-xylopyranosyl-(1→4)-β-d-glucopyranosyl-(1→4)][α-l-rham-nopyranosyl-(1→3)]-β-d-glucopyranosyl-(1→3)-α-l-rhamnopyranosyl-(1→2)-α-arabi-nopyranosyl-hederagenin | C76H124O40 | CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)CO)OC4C(C(C(CO4)O)O)O)O)O)CO)OC5C(C(OC(C5O)OC6C(C(COC6OC7CCC8(C(C7(C)CO)CCC9(C8CC=C1C9(CCC2(C1CC(CC2)(C)C)C(=O)OC1C(C(C(C(O1)COC1C(C(C(C(O1)CO)O)O)O)O)O)O)C)C)C)O)O)C)O)O)O)O)O | ||
| TCMBANKIN060348 | 26-o-beta-d-glucopyranosyl(25r)-5alpha-furostane-12-one-3beta,22alpha,26-triol-3-o-beta-d-glucopyranosyl-(1-2)-beta-d-galactopyranoside;26-o-β-d-glucopyranosyl(25r)-5α-furostane-12-one-3β,22α,26-triol-3-o-β-d-glucopyranos-yl-(1→2)-β-d-galactopyranoside | C45H74O20 | CC1C2C(CC3C2(C(=O)CC4C3CCC5C4(CCC(C5)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)O)O)C)C)OC1(CCC(C)COC8C(C(C(C(O8)CO)O)O)O)O | ||
| TCMBANKIN060351 | proto-iso-eruboside b | C57H96O30 | 1261.4 g/mol | CC1C2C(CC3C2(CCC4C3CC(C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)CO)O)O)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)C)O)C)OC1(CCC(C)COC1C(C(C(C(O1)CO)O)O)O)O | |
| TCMBANKIN060353 | trigofoenoside d | C51H84O23 | 1065.2 g/mol | CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)O)OC7C(C(C(C(O7)CO)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)OC1(CCC(C)COC9C(C(C(C(O9)CO)O)O)O)O | |
| TCMBANKIN060482 | hecogenin 3-o-β-d-glucopyranosyl-(1→2)-β-d-glucopyranosyl-(1→4)-β-d-galactopyra-noside;terreside a;terrestrosin c | C45H72O19 | CC1CCC2(C(C3C(O2)CC4C3(C(=O)CC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)C)C)C)OC1 | ||
| TCMBANKIN060489 | 25(s)-ruscogenin 1-o-α-l-rhamnopy-ranosyl-(1→2)-β-d-xylopyranoside | C38H60O12 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(C(CC(C6)O)OC7C(C(C(CO7)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)C)OC1 | ||
| TCMBANKIN060497 | dioscin | C45H72O16 | 869.04 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 | |
| TCMBANKIN060508 | terrestrosin e | C45H74O19 | 919.19 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CC(C(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)O)C)C)C)OC1 | |
| TCMBANKIN060516 | 3-o-[bis-α-l-rhamnopyranosyl-(1→2and1→4)-β-d-glucopyranosyl]-25r-furost-5-ene-3β,22α,26-triol | C45H74O17 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 | ||
| TCMBANKIN060517 | terrestrosin a | C45H74O18 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)C)C)C)OC1 | ||
| TCMBANKIN061288 | donasine | C11H14N2 | 174.24 g/mol | CN(C)CC1=CNC2=CC=CC=C21 | |
| TCMBANKIN061574 | feruloyltyramine | n- cis-feruloyltyramine; NP-001984; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; NCGC00169550-01; N-Trans-Feruloyl Tyramine; Moupinamide, >=95% (LC/MS-ELSD); 66648-43-9; Alfrutamide; trans-N-Feruloyltyramine; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; N-Feruloyltyramine; ZINC901461; MEGxp0_000693; Feruloyltyramine; Moupinamide; BRD-K98045316-001-01-0; MolPort-001-740-847; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; MCULE-4768764740; n-trans-feruloyl-tyramine; W1092; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; ACon1_001233; N-trans-Feruloyltyramine; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; CHEMBL206555; 65646-26-6; n- trans-feruloyltyramine; N-Transferuloyl Tyramine; MFCD17214811; AKOS025287596; CHEBI:17818; C02717; AC1NQX6M; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; CHEBI:17818; 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS113439; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; N-trans-Feruloyltyramine; C02717; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; N-Feruloyltyramine; 65646-26-6; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS-113439; 66648-43-9; Feruloyltyramine; moupinamide; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; ACon1_001233; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; MEGxp0_000693; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-, (2Z)-; 80510-09-4; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; Moupinamide; n-trans-feruloyltyramine; N-E-feruloyl tyramine; n-cis-feruloyltyramine | C18H19NO4 | 313.3 g/mol | COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CC=C(C=C2)O)O |
| TCMBANKIN061802 | tataramide A | tribulusamide a;tataramide B;grossamide;tribulusamideA | C36H36N2O8 | 624.7 g/mol | COC1=CC(=CC2=C1OC(C2C(=O)NCCC3=CC=C(C=C3)O)C4=CC(=C(C=C4)O)OC)C=CC(=O)NCCC5=CC=C(C=C5)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab